Company / Operating Cash Flow per Share
ENDRA Life Sciences Inc. Operating Cash Flow per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.28
FY2020
5-year range
-$4.56 / -$0.84
FY2017-FY2020
Trend
-23.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.84 to $-1.28 over the past 2 years.
Based on SEC 10-K filings.
-1.28 in FY2020.
Declined from $-0.84 to $-1.28 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating cash flow per share decreased 23.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$1.28 | -23.0% |
| FY2019 | -$1.04 | -23.3% |
| FY2018 | -$0.84 | +81.6% |
| FY2017 | -$4.56 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026